Company intelligence / Profile preview
Mind Pharmaceuticals
New Haven, Connecticut, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Mind Pharmaceuticals is a clinical-stage biotech company developing psychedelic-based therapies for hard-to-treat central nervous system diseases. Their lead asset, MIND001, is an intravenous synthetic DMT formulation for treatment-resistant depression. Early trials show rapid onset and sustained efficacy with a favorable safety profile. Additional pipeline assets target migraine/cluster headache prevention and alcohol use disorder using sub-hallucinogenic doses of psilocybin[1][2][3].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculeSynthetic tryptamine (DMT)Psilocybin (sub-hallucinogenic dose)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Yale University (licensing of intellectual property and clinical trial collaboration)
Beyond the preview
Go deeper on Mind Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mind Pharmaceuticals.